502.05MMarket Cap
LossP/E TTM
Institutional Confidence
Currency: USD Updated: 2026-06-18The current institutional shareholding score of CytomX Therapeutics Inc is 7.00, ranking 81 out of 389 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 78.87%, representing a quarter-over-quarter decrease of 19.41%. The largest institutional shareholder is Bill Nygren | OAKMX, holding a total of 9.71M shares, representing 3.62% of shares outstanding, with 33.21% decrease in holdings.
Institutional Shareholding
Shareholder Activity
Fidelity Management & Research Company LLC
Longitude Capital Management Co., LLC
Kynam Capital Management LP
State Street Investment Management (US)